Heather joined Oxford Science Enterprises in March 2022, a highly experienced venture capitalist, with over 20 years investment and company building experience.
At OSE, she leads the Health Tech team to identify new opportunities, catalyse the creation of transformational new businesses, and scale up the existing portfolio, covering digital health, diagnostics and medical devices.
Heather started her career in operational roles, creating new healthcare-related businesses and spin-outs for Unilever. She transitioned to investing while at Unilever, and subsequently spent the next 15 years in venture capital, more recently with J&J, leading J&J’s consumer Health Tech investment and partnering across EMEA.
She joined OSE from Optum Ventures where she was a Partner, responsible for establishing and leading the Global Health Tech investment fund on behalf of Optum, a leading technology-enabled US health services business, part of UnitedHealth Group.
Heather holds a PhD in Clinical Biochemistry from Queen’s University of Belfast.
